The authors found, however, that PD-L1 expression in tumours did not predict better survival outcomes in patients with high PD-L1 expression10 and a trend to better response was linked to a higher intratumoural CD8+ lymphocyte density in baseline tumour samples. This evidence concerns the gene CD8A and neoplasm.